InvestorsHub Logo
Followers 35
Posts 6308
Boards Moderated 0
Alias Born 02/09/2015

Re: Astavakra post# 93803

Saturday, 03/07/2015 7:31:08 PM

Saturday, March 07, 2015 7:31:08 PM

Post# of 403047
Quiver quibble: is this worthwhile saying? I assume you all would agree that there is a quiver in progress, but no arrows other than Brilacidin currently. All those other compounds in development may never even see the light of day. Or they may be the greatest thing since sliced bread. But none of them have ever been given to a single patient so they do not constitute a quiver.

I do not say this to be argumentative, or mean spirited, just to state the obvious. Maybe too obvious to even post. But there seems to be a sense on the board that because Brilacidin looks good so far, that the other drugs might do well too- but this is not at all a given.

Saying that B is ineffective against some bacteria is not a criticism. It would not be expected to kill every bacteria, right?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News